Literature DB >> 15736105

GPR40 gene Arg211His polymorphism may contribute to the variation of insulin secretory capacity in Japanese men.

Takeo Ogawa1, Hiroshi Hirose, Kiichi Miyashita, Ikuo Saito, Takao Saruta.   

Abstract

GPR40 is a member of the G-protein-coupled receptors. Recent studies suggest that GPR40 is highly expressed in pancreatic beta cells and insulin-secreting cell lines, and that fatty acids increase intracellular calcium concentration and amplify glucose-stimulated insulin secretion by activating GPR40. Despite identification of the Arg211His polymorphism in the GPR40 gene, there have been no clinical studies concerning this polymorphism. The present study was performed to investigate the effects of the GPR40 gene Arg211His polymorphism on clinical and metabolic parameters, including serum insulin level, in 327 healthy Japanese men, using the TaqMan polymerase chain reaction method. Serum insulin level, homeostasis model of insulin resistance (HOMA-IR), and beta-cell function (HOMA-beta were significantly different (P = .0075, .0152, and .0039, respectively) and were lowest in Arg/Arg homozygotes and highest in His/His homozygotes, although plasma glucose and serum lipids were not significantly different. Multiple regression analyses showed that serum insulin level, HOMA-IR, and HOMA- beta were significantly correlated with this polymorphism after adjusting for age and body mass index. After Bonferroni's correction for multiple comparisons was made, only HOMA- beta was significantly different among the 3 genotypes. These results suggest that the Arg211His polymorphism in the GPR40 gene may contribute to the variation of insulin secretory capacity in Japanese men.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15736105     DOI: 10.1016/j.metabol.2004.09.008

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  9 in total

1.  Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules.

Authors:  Celia P Briscoe; Andrew J Peat; Stephen C McKeown; David F Corbett; Aaron S Goetz; Thomas R Littleton; David C McCoy; Terry P Kenakin; John L Andrews; Carina Ammala; James A Fornwald; Diane M Ignar; Stephen Jenkinson
Journal:  Br J Pharmacol       Date:  2006-05-15       Impact factor: 8.739

2.  The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1.

Authors:  Nicola J Smith; Leigh A Stoddart; Nicola M Devine; Laura Jenkins; Graeme Milligan
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

3.  Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion.

Authors:  T Tomita; H Masuzaki; H Iwakura; J Fujikura; M Noguchi; T Tanaka; K Ebihara; J Kawamura; I Komoto; Y Kawaguchi; K Fujimoto; R Doi; Y Shimada; K Hosoda; M Imamura; K Nakao
Journal:  Diabetologia       Date:  2006-03-09       Impact factor: 10.122

4.  Drug discovery opportunities and challenges at g protein coupled receptors for long chain free Fatty acids.

Authors:  Nicholas D Holliday; Sarah-Jane Watson; Alastair J H Brown
Journal:  Front Endocrinol (Lausanne)       Date:  2012-01-03       Impact factor: 5.555

5.  AMG 837: a novel GPR40/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents.

Authors:  Daniel C-H Lin; Jane Zhang; Run Zhuang; Frank Li; Kathy Nguyen; Michael Chen; Thanhvien Tran; Edwin Lopez; Jenny Ying Lin Lu; Xiaoyan Nina Li; Liang Tang; George R Tonn; Gayathri Swaminath; Jeff D Reagan; Jin-Long Chen; Hui Tian; Yi-Jyun Lin; Jonathan B Houze; Jian Luo
Journal:  PLoS One       Date:  2011-11-08       Impact factor: 3.752

6.  A selective GPR40 (FFAR1) agonist LY2881835 provides immediate and durable glucose control in rodent models of type 2 diabetes.

Authors:  Yanyun Chen; Min Song; Jonathan P Riley; Charlie C Hu; Xianbu Peng; Donalyn Scheuner; Krister Bokvist; Pranab Maiti; Steven D Kahl; Chahrzad Montrose-Rafizadeh; Chafiq Hamdouchi; Anne Reifel Miller
Journal:  Pharmacol Res Perspect       Date:  2016-11-21

7.  Variants in the FFAR1 gene are associated with beta cell function.

Authors:  Martins Kalis; Per Levéen; Valeriya Lyssenko; Peter Almgren; Leif Groop; Corrado M Cilio
Journal:  PLoS One       Date:  2007-11-07       Impact factor: 3.240

Review 8.  Minireview: The effects of species ortholog and SNP variation on receptors for free fatty acids.

Authors:  Brian D Hudson; Hannah Murdoch; Graeme Milligan
Journal:  Mol Endocrinol       Date:  2013-05-17

9.  A Single Amino Acid Mutation (R104P) in the E/DRY Motif of GPR40 Impairs Receptor Function.

Authors:  Shimeng Guo; Jiandong Zhang; Shuyong Zhang; Jing Li
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.